Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

SRF Limited - Chemical biz's good performance may continue - ICICI Securities

Posted On: 2021-01-22 22:52:27 (Time Zone: Arizona, USA)


SRF Ltd's chemical business revenue and EBIT came below expectations in Q3FY21, but some of it was offset by higher margins in textiles and packaging films business. The company remains confident of achieving >25% revenue growth in specialty chemicals in FY21, and also seeing hardening of prices in HFC (ref-gas) which should start benefiting chemical business revenue and EBIT from next quarter. The company remains confident of executing guided capex of Rs15-18bn in FY22 as it already has a pipeline of Rs12-13bn capex, and expects more capex announcements of Rs3-4bn in specialty chemicals in coming quarters. This gives visibility to specialty chemicals revenue growth in FY22 and beyond. We maintain our estimates, but increase our SoTP valuations to Rs5,644 (from Rs4,652) as we rollover our valuations to FY23E. Maintain HOLD.

- Flat revenue in ref-gas hits chemical business growth. SRF's revenue rose 16% YoY to Rs21.5bn driven by strong performance in packaging film business. Chemical business revenue increased 11.6% YoY to Rs9bn on higher growth in specialty chemicals, while ref-gas revenue was flat. Packaging film revenue rose 25.7% YoY to Rs8bn on ramp-up in Thailand and Hungary. Technical textile revenue rose 9.3% YoY on faster-than-expected recovery in domestic tyre industry.

- EBITDA rose 41% YoY to Rs5.7bn. Gross profit rose 23% YoY to Rs11.3bn and margin expanded 295bps YoY to 52.5% on higher margins in packaging films. EBITDA rose 41% YoY to Rs5.7bn due to operating leverage and lower other expenses. EBIT was up 49% YoY to Rs4.5bn. PAT dipped 5.5% YoY to Rs3.2bn on negative ETR in Q3FY20. EPS dipped 6.1% YoY to Rs56.4.

- Packaging business EBIT margin started normalising to 26.5% (down 300bps QoQ) while EBIT rose to Rs2.1bn, up 42% YoY. Chemical business EBIT rose 32.8% YoY to Rs1.9bn. EBIT margin rose 330bps YoY to 21% on higher contribution from specialty chemicals and operating leverage. Technical textile segment EBIT came in at Rs679mn, up 86% on low base in Q3FY20 due to inventory loss and weak demand.

- Call highlights: 1) Specialty chemical plant utilisation are high and SRF expects new capacity addition to help future growth; 2) it continues to run campaign for 5-6 products in specialty chemicals which is limited by capacity in multipurpose plant; 3) gloss block for specialty chemical is Rs21bn; 4) HFC prices are hardening which should benefit revenue and EBITDA growth in next two quarters; 5) ref-gas demand from OEMs has recovered, and SRF is also seeing recovery in replacement demand. It has created ref-gas inventory for next two quarters and HFC plant utilisation has reached peak at exit; 6) though fluorspar prices have increased, but the company expects the prices to be manageable and are no risk to margins; and 7) packaging films margin has dipped due to the commissioning for 1 plant each in BOPET and BOPP.

Shares of SRF LTD. was last trading in BSE at Rs.5406.3 as compared to the previous close of Rs. 5774.2. The total number of shares traded during the day was 27515 in over 6557 trades.

The stock hit an intraday high of Rs. 5715 and intraday low of 5347.45. The net turnover during the day was Rs. 150313945.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Wipro - Beware of integration / impairment risks! - ICICI Securities

Easy Trip Planners Ltd - IPO Review - ICICI Direct

ICICI Direct - Derivatives Weekly View (March 5): Level of 14700 remains crucial for upsides to continue...

Easy Trip Planners Ltd. - IPO - Strong Financials - Reliance Securities

Bharat Forge - Initiating Coverage - Constant evolution - HDFC Securities

Mahindra Logistics - Large-ticket deal win - ICICI Securities

Company Update - Huhtamaki India - ICICI Direct

Gladiator Stocks: IndusInd Bank, VIP Industries - ICICI Direct

Warehousing demand expected to grow around 160% to reach 35 million sq. ft in 2021: JLL

Telecom - Spectrum auction: Prudent investment by Bharti Airtel - ICICI Securities

JB Chemicals & Pharmaceuticals - Analyst meet takeaways - ICICI Securities

IPO Review - MTAR Technologies Ltd - ICICI Direct

Auto Sector - Monthly Volume Round-up - Feb 21 - Decent YoY Growth Continues

Aditya Birla Fashion and Retail - Focus on scaling up new businesses - ICICI Securities

Automobiles (wholesale) - Wholesales push continues despite modest retail trends - ICICI Securities

Aditya Birla Capital - Thoughtful (inclusive) conglomerate business evolution commands premium - ICICI Securities

Jubilant Foodworks - Buying in-the-money options - ICICI Securities

Multi Commodity Exchange of India - Play on rising commodity prices? - ICICI Securities

Gladiator Stocks - Sudarshan Chemical - ICICI Direct

Monthly Commodities Outlook - March 2021 - ICICI Direct

ICICI Direct - Monthly Currency Outlook: Rupee to depreciate further towards 75.00 level...

ICICI Direct - Covid Recovery Pulse - E-way bill generation in February 2021 starts on strong note...

Company Update - Virtual JLR Investor Event - Tata Motors - ICICI Direct

Analyst Meet Update - Aditya Birla Fashion and Retail - ICICI Direct

MTAR Technologies Ltd. - IPO - Huge Opportunities from Clean Energy Bodes Well - Reliance Research

ICICI Direct Derivatives Weekly View (February 26): Failure to move above 14700 may extend declines towards 14300...

Bank: Sector Credit Trends - Slows, Yet again - HDFC Securities

Piramal Enterprises - Pharma day highlights - ICICI Securities

Polymer price tracker - PVC prices rise sharply again! - ICICI Securities

Greenply Industries - Growth returns, at an inflection point - ICICI Securities

Tata Motors - JLR future proofing itself with rapid electric transition - ICICI Securities

Dairy - Higher freight cost and increase in Global SMP prices - ICICI Securities

Analyst Meet Update - Nestlé India (Hold): Focus on product innovation, expanding rural reach - ICICI Direct

MTAR Technologies Ltd - A strong player in booming high precision engineering... - Geojit

Rollover Report for February - March 2021 : Angel Broking

Reaction from industry experts on Q3FY21 GDP numbers

M. Govinda Rao, Chief Economic Adviser, Brickwork ratings on Q3FY21 GDP numbers

Mr. Dhiraj Relli, MD & CEO, HDFC securities views on Q3FY21 GDP Growth Number

Suman Chowdhury, Chief Analytical Officer, Acuité Ratings & Research on Q3FY21 GDP

Rollover Analysis - Feb 21, 2021 - YES Securities

Consumer Durables - Demand-driven recovery continues - HDFC Securities

Cement - Demand surprises; earnings upgrade to continue - ICICI Securities

Gladiator Stocks - TeamLease Services - ICICI Direct

Gladiator Stocks - Metals to outshine post multi-year breakout... - ICICI Direct

Company Update - Sundaram Finance - ICICI Direct

Indian pharmaceutical industry to meet an ambition of US$130 billion by 2030 through innovation-led growth: EY-FICCI report

4th Industrial Conclave - Bullish undertone, favourable valuation - HDFC Securities

Sanofi India - Weak quarter; sequential improvement - ICICI Securities

Sunteck Realty - All eyes on upcoming launches - ICICI Securities

Company Update - Tata Motors - ICICI Direct



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020